Cheryl Cohen - 05 Jul 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Jul 2022, 16:25:46 UTC
Prior SEC filing
17 Jun 2022
Next SEC filing
15 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian G. Drazba, as attorney in fact

Key filing fact

Cheryl Cohen filed Form 4 for MEI Pharma, Inc. (MEIP) on 07 Jul 2022.

Key facts

  • This page summarizes Cheryl Cohen's Form 4 filing for MEI Pharma, Inc. (MEIP).
  • 1 reported transaction and 4 derivative rows are listed below.
  • Accepted by SEC: 07 Jul 2022, 16:25.

Change

  • Previous filing in this sequence was filed on 17 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEIP transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+87,500
Change %
Price
$0.000000
Shares after
87,500
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
87,500
Exercise price
$0.5400
Footnotes
F1
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
50,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$2.95
Footnotes
F2
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
50,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$3.49
Footnotes
F2
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$1.71
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The options will vest in equal monthly installments over twelve months.

Footnote F2

All of such options are presently exercisable.

Footnote F3

20,000 options will vest in equal monthly installments over thirty-six months from April 10, 2020 and 10,000 options shall vest in equal monthly installments over twelve months from April 10, 2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .